Skip to Content

Alkaloid AD Skopje ALK

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ALK is trading at a 10% premium.
Price
MKD 20,322.00
Fair Value
MKD 32,351.26
Uncertainty
Extreme
1-Star Price
MKD 24,768.77
5-Star Price
MKD 4,661.76
Economic Moat
Fbbdws
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALK is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
2.40%
Dividend Yield (Forward)
2.65%
Total Yield
2.40%

Company Profile

Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
2,528

Comparables

Valuation

Metric
ALK
301331
600518
Price/Earnings (Normalized)
Price/Book Value
2.224.26
Price/Sales
3.175.80
Price/Cash Flow
35.32
Price/Earnings
ALK
301331
600518

Financial Strength

Metric
ALK
301331
600518
Quick Ratio
0.764.200.75
Current Ratio
1.724.911.36
Interest Coverage
91.9029.44−23.45
Quick Ratio
ALK
301331
600518

Profitability

Metric
ALK
301331
600518
Return on Assets (Normalized)
5.69%−10.05%
Return on Equity (Normalized)
6.84%−20.55%
Return on Invested Capital (Normalized)
7.12%−19.41%
Return on Assets
ALK
301331
600518
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ACygnqzjtqQrlh$77.2 Bil
MKKGY
Merck KGaA ADRJxcgwkbbQryrc$75.4 Bil
HLN
Haleon PLC ADRQbhwzdbhmKrjjv$38.1 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRWrkvphvyqFhcg$16.0 Bil
VTRS
Viatris IncNfqrtbdwwGsxwt$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRMrgrtntVfmz$12.1 Bil
CTLT
Catalent IncXcdbsffhJgdjn$10.2 Bil
PRGO
Perrigo Co PLCWsngnmvxPshl$4.3 Bil
CURLF
Curaleaf Holdings IncFftffjlhWnpw$4.0 Bil
PBH
Prestige Consumer Healthcare IncBnsqsvffYvvfc$3.6 Bil

Sponsor Center